KROS — Keros Therapeutics Share News
0.000.00%
Last trade - 00:00- $223.65m
- -$33.96m
- $244.06m
Brief: Keros Therapeutics Announces Closing Of Upsized Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Crypto stocks, US insurers, EPAM Systems
U.S. STOCKS ON THE MOVE-Apple, Lamb Weston, Dyne Therapeutics
Keros Therapeutics rises after upsized stock offering
Brief: Keros Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
Brief: Keros Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Keros Therapeutics To Develop Ker-065 For The Treatment Of Obesity
U.S. RESEARCH ROUNDUP-Adobe, Oracle, Visa
Brief: Keros Therapeutics Says Durable Clinical Responses Associated With Improvements In Patient-Reported Measures Of Fatigue
Brief: Keros Therapeutics Q3 EPS USD -1.33
Keros Therapeutics Inc expected to post a loss of $1.35 a share - Earnings Preview
Keros Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Keros Therapeutics Q2 EPS USD -1.27
Keros Therapeutics Inc expected to post a loss of $1.34 a share - Earnings Preview
Brief: Keros Therapeutics Presents Study Results
Keros Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Keros Therapeutics Inc expected to post a loss of $1.12 a share - Earnings Preview
Brief: Keros Therapeutics Appoints Alpna Seth, Ph.D., To Its Board Of Directors
Keros Therapeutics Inc reports results for the quarter ended in December - Earnings Summary